Today: 19 May 2026
Browse Category

NYSE:OSCR 3 October 2025 - 12 May 2026

Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health shares rose 3.3% to $12.66 in premarket trading after forecasting 2026 revenue of $18.7–$19.0 billion and operating earnings of $250–$450 million. The company posted a wider Q4 net loss of $353 million and a medical loss ratio of 95.4%. A U.S. House panel subpoenaed Oscar and other insurers over ACA subsidy practices. Oscar also disclosed a new $475 million revolving credit facility.
10 February 2026
·
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health shares traded near $16.63 on December 15, 2025, as the ACA open enrollment deadline coincided with new analyst coverage and policy debate in Washington. Congress is weighing the fate of enhanced ACA premium tax credits set to expire at the end of 2025. KFF projects average subsidized premiums could more than double in 2026 if subsidies lapse. Oscar’s business is heavily exposed to these ACA marketplace shifts.
15 December 2025
·
Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health shares traded near $15.80 on Thursday after closing at $15.59, down 8% despite broader market gains. Stephens & Co. initiated coverage with an “Equal-Weight” rating and a $17 price target. Analyst targets now range from $11 to $25, with volatility metrics remaining elevated. The stock’s 52-week range is $11.20 to $23.80, and market cap stands at about $4.1 billion.
11 December 2025
·
Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health shares jumped 8–9% to about $18.20 by mid-afternoon Wednesday, November 26, 2025, with volume topping 10 million shares. The surge followed a Piper Sandler upgrade to “Overweight” and a new $25 price target, citing Oscar’s margin strategy and earnings potential even if ACA subsidies lapse. Earlier in November, major banks had maintained bearish ratings and lower targets.
26 November 2025
··
Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health shares rose as much as 20% in premarket trading Monday after reports that the White House may propose a two-year extension of enhanced ACA subsidies, with new eligibility limits. The stock traded at $15.47, up about 15% as of 7:56 a.m. ET, according to RTTNews. Oscar recently reported Q3 revenue up 23% year over year to $2.93 billion and membership above 2 million.
24 November 2025
···
Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health announced new individual-market plans for Miami-Dade and four nearby South Florida counties, effective January 1, 2026, with enrollment via HealthCare.gov. The company also introduced HelloMeno, a menopause-focused plan with Elektra Health, available in multiple states for 2026. Managed-care stocks fell after Trump criticized ACA subsidies, pressuring marketplace insurers.
10 November 2025
··
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health reported Q3 revenue of $2.99 billion, up 23% year-over-year but below analyst estimates. The company posted a net loss of $137.5 million, or –$0.53 per share, beating EPS expectations. Medical loss ratio rose to 88.5%. Oscar exchanged $187.5 million of 2031 notes for about 23.3 million shares and reaffirmed its 2025 outlook.
6 November 2025
··
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health shares jumped 11% to $21.50 on Oct. 3, 2025, and traded near $21.76 on Oct. 14, up roughly 40% year-to-date. The company announced a $410 million convertible debt offering to fund AI initiatives and launched a new employer health plan with Hy-Vee. Q2 revenue rose to about $2.9 billion, but net losses widened to $228 million. Analysts remain bearish, with an average price target near $12.
17 October 2025
··
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets on ACA Hopes and Tech-Driven Growth – Can the Insurtech Finally Turn a Profit?

Oscar Health closed at $22.30 on Oct. 6, 2025, with a market cap near $5.6 billion after surging 42% year-to-date. Q2 revenue rose 29% to $2.86 billion, but the company posted a $228 million net loss as its medical loss ratio jumped to 91.1%. Membership topped 2 million. Wall Street consensus remains “Strong Sell,” with an average 12-month price target of $12.
6 October 2025
·
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health shares traded near $19.81 midday Oct. 3, up about 2.8%, with a market cap around $4.9 billion. The company reported Q2 revenue of $2.86 billion and a $228 million net loss, serving about 2 million members, mostly in ACA exchanges. On Sep. 11, Oscar announced a $350 million convertible note offering to fund growth and retire its credit line. Analyst ratings remain cautious, with recent downgrades citing ACA risk.
3 October 2025
·

Stock Market Today

  • Tuesday Options Surge in Warby Parker, TeraWulf, Columbus McKinnon
    May 19, 2026, 4:13 PM EDT. Noteworthy options activity was recorded Tuesday in Warby Parker Inc (WRBY), with 23,646 contracts traded, equating to 81.2% of its average daily share volume. The $35 strike call expiring December 18, 2026, saw 5,076 contracts. TeraWulf Inc. (WULF) had 239,230 contracts traded, about 80% of its daily volume, driven by the $27 strike call expiring July 17, 2026, with 76,578 contracts. Columbus McKinnon Corp. (CMCO) options volume hit 1,934 contracts, or 73.4% of average daily trades, led by the $17.50 strike call expiring December 18, 2026. These spikes reveal active trading interest in key calls across the Russell 3000 components, indicating investor speculation or hedging ahead of notable dates.

Latest articles

Wall Street Just Got Hit by the Bond Market Again — What Traders Are Watching Next

Wall Street Just Got Hit by the Bond Market Again — What Traders Are Watching Next

19 May 2026
The S&P 500 fell 0.55%, Nasdaq lost 0.72%, and Dow dropped 0.47% Tuesday as Treasury yields climbed, with the 10-year at 4.67% and the 30-year at 5.18%, its highest since 2007. Brent crude hovered near $111. Home Depot rose after earnings, while Akamai slid on a $2.6 billion convertible-note offering. Investors watched Nvidia ahead of its results.
Intel Stock Bounces as Wall Street Rethinks AI Narrative

Intel Stock Bounces as Wall Street Rethinks AI Narrative

19 May 2026
Intel shares climbed 3.3% to $111.69 Tuesday afternoon, rebounding after five sessions of losses as Citi and Benchmark raised price targets, citing stronger CPU demand. Trading volume topped 112 million shares. The move came ahead of Nvidia’s earnings, which options traders expect to trigger a major market shift. Intel CEO Lip-Bu Tan was set to speak at a J.P. Morgan conference later in the day.
Pinterest shares erase post-earnings gains

Pinterest shares erase post-earnings gains

19 May 2026
Pinterest shares fell about 6% Tuesday, trading at $18.74 by 3:05 p.m. EDT, erasing gains from its May earnings rally. The drop outpaced declines in Meta, Snap, and Reddit as the Nasdaq and S&P 500 also slipped. Pinterest reported Q1 revenue of $1.008 billion, up 18%, with a net loss of $74 million. The company forecast Q2 revenue above analyst expectations.
Go toTop